Experience of the use of octreotide for refractory gastrointestinal bleeding in a patient with Jarvik2000® left ventricular assist device

Seiko Nakajima-Doi(National Cerebral and Cardiovascular Center), Norihide Fukushima(National Cerebral and Cardiovascular Center), Kensuke Kuroda(National Cerebral and Cardiovascular Center), Takuya Watanabe(Takeda (Japan)), Shigeki Miyata(Japanese Red Cross Society, Japan), Osamu Seguchi(National Cerebral and Cardiovascular Center), Köichi Toda(The University of Osaka), Yorihiko Matsumoto(National Cerebral and Cardiovascular Center), Satsuki Fukushima(National Cerebral and Cardiovascular Center), Tomoyuki Fujita(The University of Tokyo), Koichi Kokame(National Cerebral and Cardiovascular Center), Keiichiro Iwasaki, Yuka Eura(National Cerebral and Cardiovascular Center), Yasuhiro Shintani(National Cerebral and Cardiovascular Center), Masanobu Yanase(National Cerebral and Cardiovascular Center), Hiroki Mochizuki(National Cerebral and Cardiovascular Center), Junjiro Kobayashi(National Cerebral and Cardiovascular Center), Yuto Kumai(National Cerebral and Cardiovascular Center), Sachi Matsuda(National Cerebral and Cardiovascular Center), Yuki Kimura(Jichi Medical University)

Journal of Artificial Organs

July 23, 2019

Cited by 1

|Cell stem cell|2010|670

|Immunity|2001|594

|Psychogeriatrics|2009|241

|Circulation Journal|2019|224

|Arthritis & Rheumatism|2011|174

Related Papers